No Data
No Data
Express News | Evofem Biosciences Announces Issuance Of US Patent No. 11,992,472 Covering Composition And Methods For Contraception With Phexxi Vaginal Gel
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
-- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio -- -- Newly issued patent is Evofem's fifth covering Hormone-Free "In the Moment" Contraceptive Ph
10-Q: Quarterly report
Express News | Evofem Biosciences Q1 Operating Expenses USD 6.447 Million
Express News | Evofem Biosciences Q1 Pretax Profit USD -4.809 Million
Express News | Evofem Biosciences Q1 Income From Operations USD -2.844 Million
No Data